Treasury & Capital Markets / TechTalk
Profit-flush China pharma firms cast eyes south
Southeast Asia offers growth opportunity, underdeveloped market, Singapore gateway
Janette Chen
6 Feb 2024
Sign in or register for free to view content
Do not have an account? Register here
Conversation
![](https://www.theasset.com/storage/uploaded_image/1496723142assetlogo.png)
![Nelson Huang](https://www.theasset.com/storage/uploaded_image/1665731907Nelsonphoto3.jpg)
Nelson Huang
director, fixed-income and multi-asset product management, Asia-Pacific
FTSE Russell, An LSEG Business
- JOINED THE EVENT -
5th ESG Summit
Swinging into action
View Highlights
Conversation
![](https://www.theasset.com/storage/uploaded_image/1496723142assetlogo.png)
![Alexander Chan](https://www.theasset.com/storage/uploaded_image/1652165320AlexanderChan.jpg)
Alexander Chan
head of ESG client strategies, Asia Pacific
Invesco
- JOINED THE EVENT -
Webinar
Sustainable investing - the new market standard
View Highlights